Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Riverwater's Sustainable Value Strategy underperformed in Q2 2026 as small-cap stocks achieved their best first-half performance since 1991, driven almost entirely by speculative excess in AI-exposed names. The Russell 2500...
— Adam J. Peck, CFA
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Stevenato Group SpA
STVN provides drug containment and delivery solutions to pharmaceutical and biotechnology companies.
As businesses with unique and uncorrelated return drivers, Daikin and Corteva complement our existing Reversionary investments, such as pharmaceutical glass manufacturer Stevanato (STVN